102 related articles for article (PubMed ID: 9531833)
1. [Local monitoring center for clozapine (Leponex) treatment].
Bakken K; Bratlid T; Erlandsen C; Lingjaerde O; Nome S
Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1076-8. PubMed ID: 9531833
[TBL] [Abstract][Full Text] [Related]
2. Clozapine: the commitment to patient safety.
Alphs LD; Anand R
J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
[TBL] [Abstract][Full Text] [Related]
3. Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis.
Honigfeld G
Psychiatr Serv; 1996 Jan; 47(1):52-6. PubMed ID: 8925346
[TBL] [Abstract][Full Text] [Related]
4. Clozapine-induced intestinal occlusion: a serious side effect.
Pelizza L; De Luca P; La Pesa M; Borella D
Acta Biomed; 2007 Aug; 78(2):144-8. PubMed ID: 17933283
[TBL] [Abstract][Full Text] [Related]
5. Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme.
Hill GR; Harrison-Woolrych M
N Z Med J; 2008 Oct; 121(1283):68-75. PubMed ID: 18841187
[TBL] [Abstract][Full Text] [Related]
6. Fatal venous thromboembolism associated with antipsychotic therapy.
Farah RE; Makhoul NM; Farah RE; Shai MD
Ann Pharmacother; 2004 Sep; 38(9):1435-8. PubMed ID: 15280515
[TBL] [Abstract][Full Text] [Related]
7. Myocarditis due to clozapine.
Prescrire Int; 2001 Jun; 10(53):83. PubMed ID: 11718172
[TBL] [Abstract][Full Text] [Related]
8. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P
Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
[TBL] [Abstract][Full Text] [Related]
9. Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device.
Kelly DL; Ben-Yoav H; Payne GF; Winkler TE; Chocron SE; Kim E; Kitchen C; Stock V; Vyas G; Love RC; Wehring HJ; Sullivan KM; Feldman S; Liu F; McMahon RP; Ghodssi R
Clin Schizophr Relat Psychoses; 2018; 12(1):23-30. PubMed ID: 26218235
[TBL] [Abstract][Full Text] [Related]
10. Clozapine--a dangerous drug in a clozapine-naïve subject.
Stanworth D; Hunt NC; Flanagan RJ
Forensic Sci Int; 2012 Jan; 214(1-3):e23-5. PubMed ID: 21831547
[TBL] [Abstract][Full Text] [Related]
11. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.
Honigfeld G; Arellano F; Sethi J; Bianchini A; Schein J
J Clin Psychiatry; 1998; 59 Suppl 3():3-7. PubMed ID: 9541331
[TBL] [Abstract][Full Text] [Related]
12. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring.
Schulte P
Ann Pharmacother; 2006 Apr; 40(4):683-8. PubMed ID: 16595571
[TBL] [Abstract][Full Text] [Related]
13. Drug adherence: effects of decreased visit frequency on adherence to clozapine therapy.
Patel NC; Crismon ML; Miller AL; Johnsrud MT
Pharmacotherapy; 2005 Sep; 25(9):1242-7. PubMed ID: 16164397
[TBL] [Abstract][Full Text] [Related]
14. Optimizing treatment with clozapine.
Conley RR
J Clin Psychiatry; 1998; 59 Suppl 3():44-8. PubMed ID: 9541338
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of heart rate variability (HRV) for monitoring clozapine plasma levels.
Agelink MW; Sayar K; Klieser E
Pharmacopsychiatry; 2003 Jul; 36(4):166-7; authors reply 168. PubMed ID: 12905104
[No Abstract] [Full Text] [Related]
16. Clozapine-induced type-2 diabetes mellitus: possible mechanisms and implications for clinical practice.
Tovey E; Rampes H; Livingstone C
J Psychopharmacol; 2005 Mar; 19(2):207-10. PubMed ID: 15728442
[TBL] [Abstract][Full Text] [Related]
17. Total smoking cessation and clozapine treatment - a diabetogenic combination?
Brown AR; Ferriter M; Milton J
Acta Psychiatr Scand; 2011 Sep; 124(3):236-7. PubMed ID: 21644940
[No Abstract] [Full Text] [Related]
18. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
Croissant B; Hermann D; Olbrich R
Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
[TBL] [Abstract][Full Text] [Related]
19. Early recognition of clozapine-induced myocarditis.
Annamraju S; Sheitman B; Saik S; Stephenson A
J Clin Psychopharmacol; 2007 Oct; 27(5):479-83. PubMed ID: 17873680
[TBL] [Abstract][Full Text] [Related]
20. Development of a method of clozapine dosage by selective electrode to the iodides.
Teyeb H; Douki W; Najjar MF
Drug Chem Toxicol; 2012 Jul; 35(3):272-6. PubMed ID: 21939364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
